Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well ...

At the same time, drugmakers have come to rely on the U.S. market for the bulk of their revenue. In 2022, the U.S. accounted ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

The Swiss pharmaceutical company Novartis has announced significant investments in the US, days after President Donald Trump threatened to impose tariffs on foreign drugs. The company announced ...

the latest companies acting to avoid penalties from recent U.S. executive orders March 19, 2025 Novartis scraps use of diverse panels for hires in US Swiss drugmaker Novartis is ending its use of ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Swiss drugmaker Novartis is planning to spend $23 billion at 10 of its U.S. facilities — including one in Millburn — as the company and the pharmaceutical industry as a whole grapple with the ...